VirScan® Viral Proteome PhIP-Seq

The Proteomes of Most Vertebrate Viruses in a Single Assay

VirScan®, an application of Phage ImmunoPrecipitation Sequencing (PhIP-Seq), is composed of the proteomes of most vertebrate viruses.

REQUEST INFO
  • PROMO: For a limited time, we're offering first-time customers 50% off PhIP-Seq analysis of 10 samples.
  • LEARN MORE

VirScan® PhIP-Seq Overview

Phage ImmunoPrecipitation Sequencing (PhIP-Seq) is a powerful method of multiplexed analysis that combines DNA high-throughput sequencing with next-generation proteomics

VirScan allows researchers to determine what antibodies were created by an individual’s unique history of viral exposures. PhIP-Seq is the highest-coverage antigen-specific assay yet developed, able to detect antibodies versus virtually any antigen via overlapping long peptides. VirScan enables simultaneous epitope-level autoantibody profiling versus most vertebrate viruses.

VirScan Overview Figure

VirScan Technology Overview

Data and technology validated by scientists

"This (VirScan) assay, which uses phage display immunoprecipitation and sequencing, is a sensitive and focused high-comprehensive approach that enables thorough serological profiling of antiviral antibodies in humans and, consequently, the identification of viral exposure throughout the human virome."

Faculty of MedicineResearch Institution (as mentioned in "Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8+ T cells in patients with advanced NSCLC" - Science Advances - November 2023)

Data and technology validated by scientists

"We elected to use the HuProt Microarray because it is an extensive platform that contains over 21,000 unique, individually purified full-length human proteins and protein isoforms in duplicate, covering more than 81% of the proteome."

OncologistSchool of Medicine Research (as mentioned in "Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade" - AACR Clinical Caner Research - September 2022)

Data and technology validated by scientists

"By using (HuProt) protein arrays, we were able to evaluate a broader range of antigens compared to previous investigations."

Senior ScientistBiotech Research (poster presentation at the San Antonio Breast Cancer Symposium 2023)